๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Women fare no worse than men 10 years after attempted coronary angioplasty

โœ Scribed by Ruygrok, Peter N. ;de Jaegere, Peter P. T. ;van Domburg, Ron T. ;van den Brand, Marcel J. ;Serruys, Patrick W. ;de Feyter, Pim J.


Book ID
102651380
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
567 KB
Volume
39
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

โœฆ Synopsis


A retrospective review of cardiac events occurring in all patients who underwent attempted coronary angioplasty in the first 5 years of our experience (1980-1985) was undertaken. Follow-up data were obtained from the civil registry, hospltal records, patient, family, and referring physician. Patient survival curves were constructed and the outcome of women and men was compared. Eight hundred fifty-six patients, 172 women and 684 men with a mean age of 60.0 and 55.3 years, respectively, underwent attempted coronary angioplasty with an overall procedural success rate of 82%, 77.7% in women and 83.1% In men. Follow-up data were obtained in 837 patients (97.8%) with a mean period of 9.6 years (range 0-13.3 years).

The estimated 10 year survival in women was identical to men [79%, 95% confidence interval (CI) 72.6-85.4% vs. 78%, 95% CI 74.6-81.4%] as was the 10 year event-free survival (men 36%, 95% CI 32.WO.O% vs. women 37%, 95% CI 29.2-44.8%), with a slmllar proportion of major cardiac events-death, myocardial infarction, coronary artery bypass surgery, and repeat angloplasty. When women were matched to men for age and previous myocardial infarction, factors found to be associated with an adverse outcome, there was no significant difference. Additionally, outcome was compared after patients were matched for maximum nominal balloon sire as an estimate of vessel size, with no significant difference between women and men. At follow-up, women complained of slgnlficantly more anginal symptoms than men (59.2% vs. 44.0%, P < 0.05) and took significantly more antianginal medication.


๐Ÿ“œ SIMILAR VOLUMES